Interestingly, in NSCLC, TAZ was not identified in the dual proteomic screen as an interactor of nuclear TIAM1, nor was there an enrichment for the YAP conserved signature in TIAM1-depleted cells. The gene discussed is TIAM1; the disease is non-small cell lung carcinoma.